- WHO releases its first report on global antibiotic resistance🔍
- Antimicrobial resistance🔍
- Antimicrobial Resistance Overview 🔍
- The Urgent Need Regenerating antibacterial drug discovery ...🔍
- A new class of antibiotics is cause for cautious celebration🔍
- The U.S. Government and Antimicrobial Resistance🔍
- Origin of Antibiotics and Antibiotic Resistance🔍
- WHO's antibacterial pipeline reports🔍
WHO releases report on state of development of antibacterials
WHO releases its first report on global antibiotic resistance - CIDRAP
New surveillance data released today by the World Health Organization (WHO) reveals widespread and in some cases high levels of antibiotic ...
The past, present, and future of antibiotics - Science
The Pew Trust maintains a census of antibiotics in various stages of clinical development (32). They report that there were 43 antibiotics in ...
Antimicrobial resistance - OECD
The rising resistance to third-line antibiotics – the drugs that are considered as the last line of defence against serious illness – poses a worrisome threat ...
Antimicrobial Resistance Overview (AMR) - USDA
USDA's Role in Addressing Antimicrobial Resistance The United States Department of Agriculture (USDA) is responsible for protecting American agriculture and ...
The Urgent Need Regenerating antibacterial drug discovery ...
There is an urgent need for the development of models that help us to do so. RECOMMENDATIONS. The reports of the three expert evidence days – research, ...
A new class of antibiotics is cause for cautious celebration - Nature
The threat of antimicrobial resistance means that new antibiotics need to be used sparingly. Governments must support their development with a long-term ...
The U.S. Government and Antimicrobial Resistance - CSIS
The United States should exercise significant global leadership around AMR, including advancing pooled international resources for antibiotic ...
Origin of Antibiotics and Antibiotic Resistance, and Their Impacts on ...
Proposals for modifying the regulatory process to facilitate antibiotic development are presented. The withdrawal of major pharmaceutical firms from antibiotic ...
WHO's antibacterial pipeline reports - The Lancet
Despite this attention from WHO, global pharmaceutical companies focusing on antibiotic development have given up their treasure hunt for new candidates, ...
AMR: Antimicrobial resistance to lower global life expectancy by 1.8 ...
This includes, per an accompanying news release, securing funding “to tackle the dwindling research and development pipeline for new antibiotics ...
GAO-17-189, ANTIBIOTICS: FDA Has Encouraged Development ...
The Food and Drug Administration (FDA) released updated or new guidance for antibiotic development, and used the qualified infectious disease ...
Knowledge Portal: Novel Antibiotics Research & Development
Stay up to date with the latest news and information about our pipeline projects, novel antibiotics research, antimicrobial development efforts, and C. diff ...
November 18-24, 2024: Antibiotic Awareness Week
WHEREAS, the COVID-19 pandemic has reversed progress in the fight against antimicrobial resistance; and,. WHEREAS, antibiotics are an important ...
PRESS RELEASE: High-Level Meeting on Antimicrobial Resistance
Collective effort to address a challenge to health, food security, and development ... 21 September 2016, New York – World leaders today signaled ...
FACT SHEET: Over 150 Animal and Health Stakeholders Join White ...
In March 2015, the Administration released the National Action Plan for Combating Antibiotic-Resistant Bacteria, a comprehensive plan that ...
Not enough new antibiotics in the pipeline, concludes WHO review
“In the five years covered by this report, we have had just 12 antibiotics approved, with only one of these – Cefiderocol– able to target all ...
WHO releases report on state of development of antibacterials
The World Health Organization (WHO) today released its latest report on antibacterial agents, including antibiotics, in clinical and preclinical development ...
2019 ANTIBACTERIAL AGENTS IN CLINICAL DEVELOPMENT
This report is the WHO's third annual review of the clinical antibacterial pipeline to analyse how the pipeline has responded to the WHO priority pathogens list ...
Confronting antimicrobial resistance 2024 to 2029 - GOV.UK
In 2023, the KAW branding was used in Scotland to promote an 'antibiotic amnesty' campaign encouraging people to return unused antibiotics to ...
Breaking through the Wall - Bundesministerium für Gesundheit
United States Biomedical Advanced Research and Development Authority ... Figure 5 | Report is focused on high-impact levers in antibiotics research and ...